Interne link ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026 september 09, 2026 om 12:00 PM UTC
Interne link ProQR to Participate in Upcoming Investor Conferences in September 2026 september 02, 2026 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2026 Operating and Financial Results augustus 13, 2026 om 11:00 AM UTC
Interne link ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement juni 25, 2026 om 10:35 AM UTC
Interne link ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform juni 25, 2026 om 10:25 AM UTC
Interne link ProQR Announces First Quarter 2026 Operating and Financial Results mei 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform mei 11, 2026 om 12:00 PM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 mei 04, 2026 om 12:00 PM UTC
Interne link ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors april 30, 2026 om 12:00 PM UTC
Interne link ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event april 08, 2026 om 08:00 PM UTC
Interne link ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board april 08, 2026 om 12:00 PM UTC
Interne link ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 maart 25, 2026 om 12:00 PM UTC
Interne link ProQR Announces Year End 2025 Operating and Financial Results maart 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference maart 03, 2026 om 09:30 PM UTC
Interne link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook januari 08, 2026 om 01:00 PM UTC
Interne link ProQR Therapeutics Added to NASDAQ Biotechnology Index december 24, 2018 om 12:00 PM UTC
Interne link ProQR annonce la publication dans Nature Medicine des données du QR-110 pour l’amaurose congénitale de Leber 10 december 18, 2018 om 03:27 PM UTC
Interne link ProQR Announces Publication in Nature Medicine of QR-110 Data for Leber’s Congenital Amaurosis 10 december 17, 2018 om 04:52 PM UTC
Interne link ProQR Announces Strategic Changes to the Management Team and Key New Hires december 13, 2018 om 12:00 PM UTC
Interne link ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10 december 10, 2018 om 12:00 PM UTC
Interne link ProQR Announces Clearance of IND to Start Clinical Trial of QR-421a in Usher Syndrome Type 2 Patients december 04, 2018 om 12:00 PM UTC
Interne link ProQR to Present at the Evercore ISI HealthConX Conference november 20, 2018 om 12:00 PM UTC
Interne link ProQR Announces Financial Results for the Third Quarter of 2018 november 07, 2018 om 12:00 PM UTC
Interne link ProQR Announces Presentations at the European Oligonucleotide and Peptide Therapeutics Conference oktober 31, 2018 om 11:00 AM UTC